MANGANELLI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 1.027
EU - Europa 836
AS - Asia 135
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.000
Nazione #
US - Stati Uniti d'America 1.026
GB - Regno Unito 277
IE - Irlanda 181
SE - Svezia 130
CN - Cina 118
UA - Ucraina 95
DE - Germania 41
FR - Francia 41
IT - Italia 25
FI - Finlandia 19
ES - Italia 12
BE - Belgio 6
IN - India 6
IR - Iran 5
NL - Olanda 3
JP - Giappone 2
PL - Polonia 2
TR - Turchia 2
AU - Australia 1
CA - Canada 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
HU - Ungheria 1
KZ - Kazakistan 1
RO - Romania 1
VN - Vietnam 1
Totale 2.000
Città #
Southend 262
Dublin 179
Fairfield 151
Chandler 115
Menlo Park 104
Ashburn 81
Jacksonville 74
Woodbridge 59
Cambridge 49
Seattle 48
Wilmington 47
Houston 45
Ann Arbor 39
New York 34
Beijing 31
Princeton 31
Nanjing 24
Boardman 11
Nanchang 11
Siena 11
Málaga 10
San Mateo 10
San Diego 8
Shanghai 8
Brussels 6
Dearborn 6
Shenyang 6
Düsseldorf 5
Helsinki 5
Jiaxing 5
Ningbo 5
Zanjan 5
Bangalore 4
Changsha 4
Hebei 4
Amsterdam 3
Guangzhou 3
Norwalk 3
Tianjin 3
Asciano 2
Chicago 2
Hefei 2
Izmir 2
Jinan 2
Kunming 2
Palomares del Rio 2
Radomsko 2
Zhengzhou 2
Bologna 1
Budapest 1
Can Tho 1
Changchun 1
Copenhagen 1
Cornigliano 1
Fontanellato 1
Fremont 1
Fuzhou 1
Hangzhou 1
London 1
Melbourne 1
Oral 1
Osaka 1
Pfaffnau 1
Prescot 1
Ravenna 1
Redwood City 1
Syracuse 1
Taizhou 1
Tappahannock 1
Tokyo 1
Venezia 1
Washington 1
Winnipeg 1
Yellow Springs 1
Totale 1.553
Nome #
Combination therapy with montelukast and ketotifen for arthritis and rash resulting from idiopathic hypereosinophilic syndrome. 174
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 169
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 160
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 147
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study 143
Retroperitoneal fibrosis following a long-standing etanercept treatment in a spondyloarthritis patient 136
Treatment of rheumatic diseases in patients with HCV and HIV infection 128
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 115
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice 114
Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis 114
Diff Quik staining method for detection and identification of monosodium urate and calcium pyrophosphate crystals in synovial fluids 104
Guillain-Barré syndrome following adalimumab treatment. 92
Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection 89
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 89
HCV e malattie autoimmuni 88
Low-dose corticosteroid induced Kaposi sarcoma in psoriatic arthritis: A case report [Su di un caso di artrite psoriasica in trattamento con cortisonici a basse dosi associato a Sarcoma di Kaposi] 84
Good Clinical Response, Remission, and Predictors of Remission in Rheumatoid Arthritis Patients Treated with Tumor Necrosis Factor-alpha Blockers: The GISEA Study. 76
Totale 2.022
Categoria #
all - tutte 5.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.878


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201981 0 0 0 0 0 0 0 0 0 0 39 42
2019/2020389 43 12 27 66 22 27 32 50 29 43 16 22
2020/2021304 24 26 9 39 10 50 9 46 27 18 22 24
2021/2022248 20 31 16 27 13 4 7 13 11 25 29 52
2022/2023353 19 29 48 46 40 77 1 37 34 14 4 4
2023/2024256 10 7 13 21 7 86 105 2 0 5 0 0
Totale 2.022